Urinary IncontinenceNCT03485872
Urinary Incontinence Self-Screen for Healthy Aging
A study testing Self-Screening and Referral Information in people with Urinary Incontinence, run by University of British Columbia at 1 site in Canada.
Trial summary
The purpose of this study is to increase awareness and timely treatment of urinary incontinence through a self-screening process. This is a 3 month study involving 2 activities; one taking place at the beginning of study and another 3 months later. Participants will be randomized into experimental and control groups. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Urinary Incontinence
- What is being tested?
- Self-Screening and Referral Information
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 53 participants
- Where
- 1 siteCanada
- Study dates
- 11 Mar 2018to 31 Aug 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Adults 65 years of age and older
- Attend a local Senior's Centre or organization
- Report having some UI symptoms
- Living independently
- Ambulatory
- No more than mild cognitive impairment
- Able to read and write in English or have someone who can assist with reading the data collection information and can complete a paper survey independently
Who cannot join
- Cognitive impairment
- Require more than minimal assistance with completing the survey
- Any impairment (e.g., vision) that would make self-screening and follow up challenging.
- Have been referred to a UI specialist or continence program in the past
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Urinary Incontinence Self-Screening for Healthy Aging
The purpose of this study is to increase awareness and timely treatment of urinary incontinence through a self-screening process. This is a 3 month study involving 2 activities; one taking place at the beginning of study and another 3 months later. Participants will be randomized into experimental and control groups. The experimental group will receive a demographic questionnaire, quality of life questionnaire, a questionnaire pertaining to urinary symptoms, information about how to self-screen for urinary incontinence and information regarding how to refer oneself to urinary incontinence resources. The control group will receive the demographic and quality of life questionnaires only. It is estimated that it will take participants 20-30 minutes to complete their package of questionnaires. After 3 months, the participants will receive a phone call inquiring into what actions they have taken regarding their urinary incontinence.
Read the detailed description
Objectives: The overall aim is to increase awareness of urinary incontinence in community-based older adults and promote timely treatment. To achieve this aim the project objectives will include:
- To develop a self-screening process for community-based older adults
- To test the use of a self-screening process with community-based older adults
Methods:
Study Design: This study will use a pilot randomized control trial to test the effectiveness of a self-screening process with older adults. The hypothesis is that older adults exposed to the self-screening process will follow up with health professionals to receive help for the UI condition. There will be two groups of older adults. The intervention group will participate in self-screening and the control will not be exposed to self-screening. Using this approach is necessary to determine whether or not the self-screening works.
Setting: Senior's Centers and organizations dedicated to seniors in Kelowna, West Kelowna and Lake Country will serve as the recruitment sites for this study. These Senior's Centers/organizations (e.g., Lake Country Seniors Centre, Lake Country Health Planning Society, Westside Health Network, Seniors Outreach Bureau) serve large and different populations of seniors (>300 seniors) so overlap in membership is not expected to be an issue. Excel randomization function will be used to assign participants to one of the two arms (the arm receiving the self-screening process or the arm not receiving this process). The randomization assignments (allocations) will be placed in individual sealed envelopes. After informed consent is obtained, the Research Assistant (RA) will choose the next available envelope to reveal which arm the study participant will be assigned.
Data Collection:
Pre-test: Prior to implementation, the self-screening tool will be pre-tested with 5 older adults attending participating seniors centres/organizations. The purpose of the pretest will be to identify any implementation issues such as recruitment, administration, understanding and ease of use of the self-screening tools.
Procedures: Older adults assigned to both groups will receive follow up from the RA who will provide details about the study and answer any questions. Prior to randomization, consenting older adults from both groups will complete a demographic (e.g., age, sex, highest level of education, household income), health history profile (e.g., co-morbidities, history of previous referrals for UI, medications) (see Demographic and Health History Profile) and a quality of life questionnaire 17 (see The King's Health Questionnaire).
Three months following study entry participants from both groups will receive a phone follow-up to obtain information about actions they have taken re IU (e.g., self/physician referral), UI symptoms, treatments received, satisfaction with care, and changes in quality of life. The follow up phone call will be recorded. It is expected the baseline and 3 month follow up data collection will take approximately 20-30 minutes to complete.
Post-Intervention Focus Groups: To obtain feedback on the self-screening process, focus groups (n=2) will be conducted with older adults (10-12 participants) who were in the self-screening group. At the end of 3-months from study entry, in conjunction with survey completion, participants will be invited to participate in a focus group. Those expressing an interest in focus group participation will be contacted with details of the date, time of the focus group and will receive a copy of the semi-structured interview questions. Questions will address participants' comfort with the self-screening process, rationale and influences on choice to self-refer or not, barriers/facilitators to self-referral, recommendations to make the self-screening process easier.
Data Analysis: Analysis will include a description of sample and primary and secondary analyses.
Description of Sample:
Frequency analysis will be conducted on all demographic (age, sex, highest level of education, household income), health history profile (co-morbidities, history of previous referrals for UI, medications) and quality of life. For continuous variables, means with associated standard deviations (SD) will be calculated for parametric variables or medians with associated interquartile ranges will be calculated for nonparametric variables. For categorical variables, percentages with 95% confidence interval (CI) will be calculated. These calculations will be calculated for the total study population as well as for participants in each study group.
Primary analysis:
The study hypothesis is that older adults exposed to the self-screening process will follow-up with health professionals to receive help for their UI condition more often than the control group. To test this hypothesis investigators will calculate the proportion (with 95% CI) of participants who self-report as having self-referred to a health professional (binary yes/no response) during the study period for each group. A chi-square test will be conducted to determine if the self-screening process is associated with self-referral to a health professional. In addition, a logistic regression analysis will be conducted to model the odds of self-referring among participants who have undergone self-screening, adjusting for demographics, and health history variables. Bivariate analysis will be conducted and variables significantly associated with self-referral will be entered into the model. Since the sample size will only allow for having 3 variables in the model, more than one regression model may be necessary. If this is the case, a Bonferroni adjustment will be used to account for multiple comparisons.
Secondary analysis:
Quality of life scores will be compared within and between groups. For the within group comparison, a two-sided dependent t-test will be conducted using the pre study and 3-month quality of life scores for each group. To determine if a change in quality of life (difference between pre study and 3-mont quality of life scores) is statistically significant and mixed between-within subjects analysis of variance will be conducted.
All participants will complete a Urinary Symptoms questionnaire (ICIQ-FLUTS) which consists of ordinal categorical responses to questions related to urinary symptoms. Each question has five response options. For each question, each response category will be assigned a numeric value depending on the severity of the symptom (1= no symptoms; 5=severe symptoms). For each participant, improvement in symptoms will be determined by a reduction in the ordinal value. Improvement in UI symptoms will be compared between groups using a chi-square test.
Investigators are also interested in knowing if self-screening results in higher proportion of participants initiating medication of UI during the study period. Therefore, the proportion of participants in each group who started medication for UI during the study period will be compared using a chi-square test.
Limitations: It is possible that screening for eligibility for the study may make a person more likely to self-refer. If this occurs in the control arm, it may bias the results toward the null hypothesis (i.e. it may be less likely to detect a difference between study arms).
- Conditions
- Urinary Incontinence
- Being tested
- Self-Screening and Referral Information, Standard Care
- Medical subject headings
- Urinary Incontinence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Self-Screening and Referral InformationOther
Urinary incontinence self-screening questionnaire, fact sheet and self-referral information will be provided by mail or email.
Standard CareOther
Demographic and quality of life questionnaires; standard care provided by participants' GPs
| Study group | Role | What they receive |
|---|---|---|
| Self-Screening and Referral Information | Experimental | The intervention will include a combination of self-screening and UI specific information and resources. Older adults in the intervention group will complete a gender specific UI Self-Screening tool. Men will complete the International Consultation on Incontinence Modular Questionnaire (ICIQ) for Males and women will complete the ICIQ for Females. In addition, the intervention group will receive a fact sheet with UI specific information, contact information to the local incontinence clinic and a link to a website with patient incontinence resources and education. Receives: Other: Self-Screening and Referral Information |
| Control Group | Active comparator | Older adults assigned to the control group will receive standard care from their physicians. Standard care may differ from general practitioner to general practitioner. Usual care for urinary incontinence (UI) from general practitioners is generally minimal. Most patients do not tell their physicians about UI, and most physicians do not ask about UI. If this topic does come up during a GP appointment, a patient may be offered no treatment, lifestyle advice (e.g., do not drink before bed), told to do Kegels (but likely not instructed how to do these properly) or in some cases, offered pharmacological therapies (which will be captured in our questionnaire with the participants). But standard of care is unfortunately very often no care. Receives: Other: Standard Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-Referral Questionnaire
The primary outcome will be the number of older adults who take action to receive help for their UI. The following question will be asked through a questionnaire at three month follow-up: "During the past three months, what have you done about the leakage?" Participants will have the option to check off any of the following options: "I haven't done anything about it", "have seen my GP about it", and "referred myself to the local Urinary Incontinence Clinic".
Measured: 3 months
Secondary outcomes (2)
Treatments Received Questionnaire
The treatments the participants receive as a result of self-referral for their urinary incontinence will be noted. The following question will be asked through a questionnaire at three month follow-up: "What treatments have you received?" Participants will have the option to check off any of the following options: Lifestyle treatments/education by a health care practitioner (ex. fluid management, kegel exercises, etc.)"; "prescription medication treatments"; and "surgical treatments".
Measured: 3 months
Satisfaction with Care Questionnaire
Participants' satisfaction with the care they receive will be observed, factoring in whether or not they received the intervention. The following question will be asked through a questionnaire at three month follow-up: "How satisfied have you been with the care you have been receiving for urinary incontinence?" Participants will have the option to check off one of the following options: "poor", "fair", "good", "very good", or "excellent".
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Apr 2018
- Study start11 Mar 2018
- Primary completion2 Jul 2019
- Study completion31 Aug 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Urinary IncontinenceStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 53 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- Retired Teachers of Ontario Foundation, Interior Health
- Responsible party
- Principal investigator, Kathy Rush, University of British Columbia
- Investigators
- Kathy Rush, PhD, Principal investigator, University of British Columbia- Okanagan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03485872
- Sponsor's protocol ID
- H17-03037
- Status last verified
- Nov 2020
- First submitted
- 7 Mar 2018
- Last updated
- 4 Nov 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Donovan JL, Abrams P, Peters TJ, Kay HE, Reynard J, Chapple C, De La Rosette JJ, Kondo A. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol. 1996 Apr;77(4):554-62. doi: 10.1046/j.1464-410x.1996.93013.x.
PubMed 8777617Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996 Jun;77(6):805-12. doi: 10.1046/j.1464-410x.1996.00186.x.
PubMed 8705212Okamura K, Nojiri Y, Osuga Y. Reliability and validity of the King's Health Questionnaire for lower urinary tract symptoms in both genders. BJU Int. 2009 Jun;103(12):1673-8. doi: 10.1111/j.1464-410X.2008.08335.x. Epub 2009 Jan 9.
PubMed 19154505
Study at a glance
From the registry record, last updated by the sponsor on 4 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Urinary Incontinence Self-Screening for Healthy Aging
- ClinicalTrials.gov ID
- NCT03485872
- Acronym / sponsor ID
- H17-03037
- Conditions
- Urinary Incontinence
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 53 participants (actual)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Collaborators
- Retired Teachers of Ontario Foundation, Interior Health
- Study start
- 11 Mar 2018 (actual)
- Primary completion
- 2 Jul 2019 (actual)
- Study completion
- 31 Aug 2019 (actual)
- First posted
- 2 Apr 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to increase awareness and timely treatment of urinary incontinence through a self-screening process. This is a 3 month study involving 2 activities; one taking place at the beginning of study and another 3 months later. Participants will be randomized into experimental and control groups. The experimental group will receive a demographic questionnaire, quality of life questionnaire, a questionnaire pertaining to urinary symptoms, information about how to self-screen for urinary incontinence and information regarding how to refer oneself to urinary incontinence resources. The control group will receive the demographic and quality of life questionnaires only. It is estimated that it will take participants 20-30 minutes to complete their package of questionnaires. After 3 months, the participants will receive a phone call inquiring into what actions they have taken regarding their urinary incontinence.
Detailed description
Objectives: The overall aim is to increase awareness of urinary incontinence in community-based older adults and promote timely treatment. To achieve this aim the project objectives will include:
- To develop a self-screening process for community-based older adults
- To test the use of a self-screening process with community-based older adults
Methods:
Study Design: This study will use a pilot randomized control trial to test the effectiveness of a self-screening process with older adults. The hypothesis is that older adults exposed to the self-screening process will follow up with health professionals to receive help for the UI condition. There will be two groups of older adults. The intervention group will participate in self-screening and the control will not be exposed to self-screening. Using this approach is necessary to determine whether or not the self-screening works.
Setting: Senior's Centers and organizations dedicated to seniors in Kelowna, West Kelowna and Lake Country will serve as the recruitment sites for this study. These Senior's Centers/organizations (e.g., Lake Country Seniors Centre, Lake Country Health Planning Society, Westside Health Network, Seniors Outreach Bureau) serve large and different populations of seniors (>300 seniors) so overlap in membership is not expected to be an issue. Excel randomization function will be used to assign participants to one of the two arms (the arm receiving the self-screening process or the arm not receiving this process). The randomization assignments (allocations) will be placed in individual sealed envelopes. After informed consent is obtained, the Research Assistant (RA) will choose the next available envelope to reveal which arm the study participant will be assigned.
Data Collection:
Pre-test: Prior to implementation, the self-screening tool will be pre-tested with 5 older adults attending participating seniors centres/organizations. The purpose of the pretest will be to identify any implementation issues such as recruitment, administration, understanding and ease of use of the self-screening tools.
Procedures: Older adults assigned to both groups will receive follow up from the RA who will provide details about the study and answer any questions. Prior to randomization, consenting older adults from both groups will complete a demographic (e.g., age, sex, highest level of education, household income), health history profile (e.g., co-morbidities, history of previous referrals for UI, medications) (see Demographic and Health History Profile) and a quality of life questionnaire 17 (see The King's Health Questionnaire).
Three months following study entry participants from both groups will receive a phone follow-up to obtain information about actions they have taken re IU (e.g., self/physician referral), UI symptoms, treatments received, satisfaction with care, and changes in quality of life. The follow up phone call will be recorded. It is expected the baseline and 3 month follow up data collection will take approximately 20-30 minutes to complete.
Post-Intervention Focus Groups: To obtain feedback on the self-screening process, focus groups (n=2) will be conducted with older adults (10-12 participants) who were in the self-screening group. At the end of 3-months from study entry, in conjunction with survey completion, participants will be invited to participate in a focus group. Those expressing an interest in focus group participation will be contacted with details of the date, time of the focus group and will receive a copy of the semi-structured interview questions. Questions will address participants' comfort with the self-screening process, rationale and influences on choice to self-refer or not, barriers/facilitators to self-referral, recommendations to make the self-screening process easier.
Data Analysis: Analysis will include a description of sample and primary and secondary analyses.
Description of Sample:
Frequency analysis will be conducted on all demographic (age, sex, highest level of education, household income), health history profile (co-morbidities, history of previous referrals for UI, medications) and quality of life. For continuous variables, means with associated standard deviations (SD) will be calculated for parametric variables or medians with associated interquartile ranges will be calculated for nonparametric variables. For categorical variables, percentages with 95% confidence interval (CI) will be calculated. These calculations will be calculated for the total study population as well as for participants in each study group.
Primary analysis:
The study hypothesis is that older adults exposed to the self-screening process will follow-up with health professionals to receive help for their UI condition more often than the control group. To test this hypothesis investigators will calculate the proportion (with 95% CI) of participants who self-report as having self-referred to a health professional (binary yes/no response) during the study period for each group. A chi-square test will be conducted to determine if the self-screening process is associated with self-referral to a health professional. In addition, a logistic regression analysis will be conducted to model the odds of self-referring among participants who have undergone self-screening, adjusting for demographics, and health history variables. Bivariate analysis will be conducted and variables significantly associated with self-referral will be entered into the model. Since the sample size will only allow for having 3 variables in the model, more than one regression model may be necessary. If this is the case, a Bonferroni adjustment will be used to account for multiple comparisons.
Secondary analysis:
Quality of life scores will be compared within and between groups. For the within group comparison, a two-sided dependent t-test will be conducted using the pre study and 3-month quality of life scores for each group. To determine if a change in quality of life (difference between pre study and 3-mont quality of life scores) is statistically significant and mixed between-within subjects analysis of variance will be conducted.
All participants will complete a Urinary Symptoms questionnaire (ICIQ-FLUTS) which consists of ordinal categorical responses to questions related to urinary symptoms. Each question has five response options. For each question, each response category will be assigned a numeric value depending on the severity of the symptom (1= no symptoms; 5=severe symptoms). For each participant, improvement in symptoms will be determined by a reduction in the ordinal value. Improvement in UI symptoms will be compared between groups using a chi-square test.
Investigators are also interested in knowing if self-screening results in higher proportion of participants initiating medication of UI during the study period. Therefore, the proportion of participants in each group who started medication for UI during the study period will be compared using a chi-square test.
Limitations: It is possible that screening for eligibility for the study may make a person more likely to self-refer. If this occurs in the control arm, it may bias the results toward the null hypothesis (i.e. it may be less likely to detect a difference between study arms).
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Self-Screening and Referral Information | Experimental | Other: Self-Screening and Referral InformationThe intervention will include a combination of self-screening and UI specific information and resources. Older adults in the intervention group will complete a gender specific UI Self-Screening tool. Men will complete the International Consultation on Incontinence Modular Questionnaire (ICIQ) for Males and women will complete the ICIQ for Females. In addition, the intervention group will receive a fact sheet with UI specific information, contact information to the local incontinence clinic and a link to a website with patient incontinence resources and education. |
| Control Group | Active comparator | Other: Standard CareOlder adults assigned to the control group will receive standard care from their physicians. Standard care may differ from general practitioner to general practitioner. Usual care for urinary incontinence (UI) from general practitioners is generally minimal. Most patients do not tell their physicians about UI, and most physicians do not ask about UI. If this topic does come up during a GP appointment, a patient may be offered no treatment, lifestyle advice (e.g., do not drink before bed), told to do Kegels (but likely not instructed how to do these properly) or in some cases, offered pharmacological therapies (which will be captured in our questionnaire with the participants). But standard of care is unfortunately very often no care. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (7 listed)
- Adults 65 years of age and older
- Attend a local Senior's Centre or organization
- Report having some UI symptoms
- Living independently
- Ambulatory
Key exclusion criteria (4 listed)
- Cognitive impairment
- Require more than minimal assistance with completing the survey
- Any impairment (e.g., vision) that would make self-screening and follow up challenging.
- Have been referred to a UI specialist or continence program in the past
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Self-Screening and Referral InformationUrinary incontinence self-screening questionnaire, fact sheet and self-referral information will be provided by mail or email. | Other | Self-Screening and Referral Information |
| Standard CareDemographic and quality of life questionnaires; standard care provided by participants' GPs | Other | Control Group |
Primary outcome
Self-Referral Questionnaire
Time frame: 3 months
The primary outcome will be the number of older adults who take action to receive help for their UI. The following question will be asked through a questionnaire at three month follow-up: "During the past three months, what have you done about the leakage?" Participants will have the option to check off any of the following options: "I haven't done anything about it", "have seen my GP about it", and "referred myself to the local Urinary Incontinence Clinic".
2 secondary outcomes
Treatments Received Questionnaire
Time frame: 3 months
Satisfaction with Care Questionnaire
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Nov 2020.
- Background: PubMed 8777617Donovan JL, Abrams P, Peters TJ, Kay HE, Reynard J, Chapple C, De La Rosette JJ, Kondo A. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol. 1996 Apr;77(4):554-62. doi: 10.1046/j.1464-410x.1996.93013.x.
- Background: PubMed 8705212Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996 Jun;77(6):805-12. doi: 10.1046/j.1464-410x.1996.00186.x.
- Background: PubMed 19154505Okamura K, Nojiri Y, Osuga Y. Reliability and validity of the King's Health Questionnaire for lower urinary tract symptoms in both genders. BJU Int. 2009 Jun;103(12):1673-8. doi: 10.1111/j.1464-410X.2008.08335.x. Epub 2009 Jan 9.
- Individual participant dataSharing planned: No
Related trials for Urinary Incontinence
Active, not recruiting
EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENCE THERAPY BALLOONS IN BLADDER EXSTROPHY AND INCONTINENT EPISPADIAS PATIENTS
Bladder Exstrophy
Recruiting
Ambulatory Long Length URodynamics Evaluation
Urology, Urinary Bladder, Overactive
Active, not recruiting
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
Not yet recruiting
Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation of the Prostate
Benign Prostatic Hyperplasia, Benign Prostatic Obstruction
Not yet recruiting
Anterior Bridge-Preserving Versus Conventional Early Apical Release During Holmium Laser Enucleation of the Prostate
Benign Prostatic Hyperplasia, Benign Prostatic Obstruction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kathy Rush, PhD principal investigator
University of British Columbia- Okanagan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Self-Screening and Referral Information in people with Urinary Incontinence, run by University of British Columbia at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-Referral Questionnaire (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03485872, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2020.